Related by context. Frequent words. (Click for all words.) 88 primary endpoint 80 primary endpoints 80 secondary endpoint 76 secondary endpoints 67 non inferiority 65 demonstrated statistically significant 63 statistically significant improvement 62 evaluable 62 clinical endpoints 61 statistically significant reduction 61 mg dose 61 statistical significance 60 evaluable patients 60 placebo 59 clinically meaningful 59 pharmacodynamic 58 placebo p 58 p = #.# [002] 58 placebo controlled 57 free survival PFS 57 Phase 2b study 57 FEV1 57 placebo p = 56 statistically significant 55 HbA1c 55 LEVADEX 55 mg kg 55 pharmacokinetic profile 55 randomized double 55 sunitinib 54 tolerability 54 ACTEMRA 54 dosing regimens 54 unblinded 54 reach statistical significance 54 double blind placebo 54 certolizumab pegol 54 P = .# 54 Phase IIb clinical 54 randomization 54 Phase 2b clinical 54 treatment emergent adverse 54 randomized placebo controlled 54 Phase 2a clinical 53 Phase IIa 53 ≥ 53 copies mL 53 post hoc 53 dose escalation 53 mg d 53 dosing regimen 53 randomized 53 p = #.# [004] 53 Phase IIa trial 53 Phase IIa clinical 53 Phase 1b 53 tiotropium 52 HCV RNA 52 randomized controlled 52 Phase 2a 52 budesonide 52 Zenvia 52 monotherapy 52 tolerability profile 52 p = 52 belimumab 52 dosing 52 infliximab 52 clinically relevant 51 n = 51 mg/m2 51 cethromycin 51 Phase Ib 51 g dL 51 pharmacokinetic 51 viral load 51 Phase IIb 51 sirolimus 51 plasma concentrations 51 mg doses 51 DSMB 51 Median survival 51 docetaxel 51 pegylated interferon 51 dexamethasone 50 midstage study 50 safety tolerability 50 dose escalation study 50 pramipexole 50 left ventricular ejection 50 mg dL 50 Bronchitol 50 allopurinol 50 dyspnea 50 statistically significant differences 50 lubiprostone 50 FOLOTYN 50 titrated 50 ticagrelor 50 INCB# [002] 50 #mg [003]